Moderna Raises $500M Financing for mRNA R&D, Manufacturing

Moderna Therapeutics has raised an additional $500 million in a financing round the company says will help it fund further R&D into its pipeline of messenger RNA (mRNA) treatment candidates.Moderna said the financing will help it continue to develop its pipeline of 19 candidates—10 of them in clinical phases—by initiating several Phase II trials, as well as corporate priorities for 2018/2019 that include:Advancing its development and delivery platform by investing in mRNA science